Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Antibactériens/usage thérapeutique,
Inhibiteurs de la pompe à protons/usage thérapeutique,
Bismuth/usage thérapeutique,
Algorithmes,
Méthode Delphi,
Association de médicaments,
Gastrite/complications,
Infections à Helicobacter,
Helicobacter pylori,
Probiotiques,
Inhibiteurs de la pompe à protons,
Récidive,
Thérapie de rattrapage,
Tumeurs de l'estomac,
Ulcère gastrique,
Échec thérapeutique,
Gastrite/traitement médicamenteux,
Infections à Helicobacter/traitement médicamenteux,
Helicobacter pylori/effets des médicaments et des substances chimiques
Carson, JL;
Guyatt, G;
Heddle, NM;
Grossman, BJ;
Cohn, CS;
Fung, MK;
Gernsheimer, T;
Holcomb, JB;
Kaplan, LJ;
Katz, LM;
Peterson, N;
Ramsey, G;
Rao, SV;
Roback, JD;
Shander, A;
Tobian, AA.
"IMPORTANCE:
More than 100 million units of blood are collected worldwide each year, yet the indication for red blood cell (RBC) transfusion and the optimal length of RBC storage prior to transfusion are uncertain.
OBJECTIVE:
To provide recommendations for the target hemoglobin level for RBC transfusion...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of gout. METHODS: Using the ACP grading system, the committee based these recommendations on a systematic review of randomized, controlled trials; ...
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glycémie,
Association thérapeutique,
Diabète de type 1,
Diabète de type 2,
Régime pour diabétique,
Surveillance des médicaments,
Endocrinologie,
Hyperglycémie,
Hypoglycémie,
Insuline/usage thérapeutique,
Pompes à insuline,
Surveillance électronique ambulatoire,
Éducation du patient comme sujet,
Médecine de précision,
Diabète de type 1/traitement médicamenteux,
Diabète de type 2/traitement médicamenteux,
Diabète de type 1/thérapie,
Diabète de type 2/thérapie,
Hypoglycémiants/usage thérapeutique,
Hypoglycémiants/effets indésirables,
Insuline/effets indésirables
Murray, MJ;
DeBlock, H;
Erstad, B;
Gray, A;
Jacobi, J;
Jordan, C;
McGee, W;
McManus, C;
Meade, M;
Nix, S;
Patterson, A;
Sands, MK;
Pino, R;
Tescher, A;
Arbour, R;
Rochwerg, B;
Murray, CF;
Mehta, S.
"OBJECTIVE:
To update the 2002 version of ""Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.""
DESIGN:
A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of neuromuscular-blocking agents; a Gra...
"OBJECTIVE:
To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the Pituit...
Nahid, P;
Dorman, SE;
Alipanah, N;
Barry, PM;
Brozek, JL;
Cattamanchi, A;
Chaisson, LH;
Chaisson, RE;
Daley, CL;
Grzemska, M;
Higashi, JM;
Ho, CS;
Ho, CS;
Hopewell, PC;
Keshavjee, SA;
Lienhardt, C;
Menzies, R;
Merrifield, C;
Narita, M;
O'Brien, R;
Peloquin, CA;
Raftery, A;
Saukkonen, J;
Schaaf, HS;
Sotgiu, G;
Starke, JR;
Migliori, GB;
Vernon, A.
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this guideline for the treatment of drug-susceptible tuberculosis, which is also endorsed by the European Respiratory Society and the US National Tube...
"BACKGROUND:
This article presents evidence-based clinical recommendations for the use of pit-and-fissure sealants on the occlusal surfaces of primary and permanent molars in children and adolescents. A guideline panel convened by the American Dental Association (ADA) Council on Scientific Affairs and th...
Soins dentaires pour enfants,
Caries dentaires,
Molaire,
Pédodontie,
Scellants de puits et fissures,
Scellants de puits et fissures/usage thérapeutique,
Scellants de puits et fissures/effets indésirables,
Caries dentaires/prévention et contrôle,
Fluorures topiques/usage thérapeutique,
Silice/usage thérapeutique,
Résines acryliques/usage thérapeutique
Fernández-Bañares, F;
Accarino, A;
Balboa, A;
Domènech, E;
Esteve, M;
Garcia-Planella, E;
Guardiola, J;
Molero, X;
Rodríguez-Luna, A;
Ruiz-Cerulla, A;
Santos, J;
Vaquero, E.
Chronic diarrhoea is a common presenting symptom in both primary care medicine and in specialized gastroenterology clinics. It is estimated that >5% of the population has chronic diarrhoea and nearly 40% of these patients are older than 60 years. Clinicians often need to select the best diagnostic approa...
Antidiarrhéiques/usage thérapeutique,
Sucres alimentaires/effets indésirables,
Algorithmes,
Maladie chronique,
Colite,
Techniques de diagnostic digestif,
Diarrhée,
Régime alimentaire,
Syndromes de malabsorption/diagnostic,
Prise en charge de la maladie,
Insuffisance pancréatique exocrine,
Hypersensibilité alimentaire,
Maladies gastro-intestinales,
Microbiome gastro-intestinal,
Motilité gastrointestinale,
Syndromes de malabsorption,
Hypersensibilité alimentaire/diagnostic,
Diarrhée/thérapie,
Diarrhée/diagnostic,
Diarrhée/classification
McCormack, FX;
Gupta, N;
Finlay, GR;
Young, LR;
Taveira-DaSilva, AM;
Glasgow, CG;
Steagall, WK;
Johnson, SR;
Sahn, SA;
Ryu, JH;
Strange, C;
Seyama, K;
Sullivan, EJ;
Kotloff, RM;
Downey, GP;
Chapman, JT;
Han, MK;
D'Armiento, JM;
Inoue, Y;
Henske, EP;
Bissler, JJ;
Colby, TV;
Kinder, BW;
Wikenheiser-Brokamp, KA;
Brown, KK;
Cordier, JF;
Meyer, C;
Cottin, V;
Brozek, JL;
Smith, K;
Wilson, KC;
Moss, J.
"BACKGROUND:
Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily affects women. The purpose of these guidelines is to provide recommendations for the diagnosis and treatment of LAM.
METHODS:
Systematic reviews were performed to summarize evidence pertinent to our questions. The e...
Facteur de croissance endothéliale vasculaire de type D,
Sirolimus/usage thérapeutique,
Sirolimus,
Biopsie,
Poumon,
Lymphangioléiomyomatose,
Tomodensitométrie,
Facteur de croissance endothéliale vasculaire de type D/sang,
Poumon/imagerie diagnostique,
Lymphangioléiomyomatose,
Lymphangioléiomyomatose/diagnostic,
Lymphangioléiomyomatose/thérapie